세계의 저침습 척추간 기기 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore

The largest subsegment of this market in 2024 was the lateral lumbar interbody fusion (LLIF). It is expected that all subsegments keep growing in value with the MIPLIF being the fastest growing. On the other hand, MIPLIF has the smallest market value share because of a high decline in prices.

The full report suite on the global market for MIS interbody devices includes subsegments for the minimally invasive interbody devices such as minimally invasive posterior lumbar interbody fusion (MIPLIF), minimally invasive transforaminal lumbar interbody fusion (MITLIF), lateral lumbar interbody fusion (LLIF) and oblique lateral interbody (OLIF).

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031, and Historical Data to 2024
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitor

GLOBAL MIS INTERBODY DEVICE MARKET TRENDS

• The major driver of this market is the increase in the elderly population relative to younger demographics and the tendency of the patients and surgeons for less invasive surgeries, as they result in less recovery time and less damage to the muscles and tissues.

Global Market Share Insights

1. 1. Globus Medical / NuVasive

• Leading competitor in the total MIS interbody device market.
• Strengthened by the merger in early 2023.
• Held leading share in North America, Western Europe and Rest of the World.

2. 2. Medtronic

• Second leading competitor in the market.
• Presence supported by Direct Lateral Interbody Fusion (DLIF(R)).
• Held second-largest share in all regions reported.

3. 3. DePuy Synthes

• Third-leading competitor globally.
• Future growth depends on innovation in the MIS market.
• Held third position in all regions reported.

Research Scope Summary

Regions

• North America (Canada, United States)
• Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
• Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
• Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
• Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2024

Forecast Period: 2025-2031

Historical Data: 2021-2023

Quantitative Data

• Market Size
• Market Shares
• Market Forecasts
• Market Growth Rates
• Units Sold
• Average Selling Prices

Qualitative Data

• Market Growth Trends
• Market Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles
• Product Portfolios
• FDA Recalls
• Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government Physician Data
• Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

MIS Interbody Device Market

• 4.1 Executive Summary
  • 4.1.1 Global MIS Interbody Device Market Overview
  • 4.1.2 Competitive Analysis
  • 4.1.3 Procedure Segmentation
  • 4.1.4 Market Segmentation
  • 4.1.5 Regions Included
• 4.2 Introduction
  • 4.2.1.1 Minimally Invasive Posterior Lumbar Interbody Fusion
  • 4.2.1.2 Minimally Invasive Transforaminal Lumbar Interbody Fusion
  • 4.2.1.3 Lateral Lumbar Interbody Fusion
  • 4.2.1.4 Direct Lateral Interbody Fusion
  • 4.2.1.5 eXtreme Lateral Interbody Fusion
  • 4.2.1.6 Guided Lateral Interbody Fusion
  • 4.2.1.7 Oblique Lateral Interbody Fusion
• 4.3 Procedure Numbers
  • 4.3.1 MIPLIF Procedures
  • 4.3.2 MITLIF Procedures
  • 4.3.3 LLIF Procedures
  • 4.3.4 OLIF Procedures
• 4.4 Market Overview
  • 4.4.1 By Segment
  • 4.4.2 By Region
• 4.5 Market Analysis and Forecast
  • 4.5.1 Total MIS Interbody Device Market
  • 4.5.2 MIPLIF Market
  • 4.5.3 MITLIF Market
  • 4.5.4 LLIF Market
  • 4.5.5 OLIF Market
• 4.6 Drivers and Limiters
  • 4.6.1 Market Drivers
  • 4.6.2 Market Limiters
• 4.7 Competitive Market Share Analysis